Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2022 Earnings Conference Call October 28, 2021 5:30 AM ET Company Participants Christopher OÂ'Reilly - Global Head, IR & Global Finance Christophe Weber - President and CEO Andy Plump - President Research and Development Costa Saroukos - CFO Masato Iwasaki - Japan General Affairs Ramona Sequeira - President, U.S. Business Unit and Global Portfolio Commercialization Julie Kim - President, Plasma-Derived Therapies Business Unit Conference Call Participants H ...